Does Dr. VIGNESH ALAMANDA have financial conflicts of interest?

Dr. VIGNESH ALAMANDA (MD) has received a total of $4,434 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $4,434 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. VIGNESH ALAMANDA?

According to CMS Open Payments data, Dr. VIGNESH ALAMANDA received funding from STRYKER CORPORATION ($2,126), SMITH+NEPHEW ($2,042), and ZIMMER BIOMET HOLDINGS ($141).

Does Dr. VIGNESH ALAMANDA receive research grants or speaking fees?

Dr. VIGNESH ALAMANDA has received $4,434 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. VIGNESH ALAMANDA

MDReal-Time Hydrated

Specialty: Orthopaedic Surgery, Adult Reconstructive Orthopaedic Surgery

Practice Location: RESTON, VA 20190

NPI Number: 1043620628

LIFETIME INDUSTRY VALUE

$4,434

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALAMANDA is a verified Orthopaedic Surgery, Adult Reconstructive Orthopaedic Surgery practitioner based in RESTON, VA.

Between 2021 and 2025, Dr. ALAMANDA had an overall industry promotional and research financial footprint of $4,434 as recorded in the federal CMS Open Payments database.

$4,434 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALAMANDA's primary funding source is STRYKER CORPORATION, which accounts for $2,126 (representing 48% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

STRYKER CORPORATION

Rank 1

$2,126

48%

SMITH+NEPHEW

Rank 2

$2,042

46.1%

ZIMMER BIOMET HOLDINGS

Rank 3

$141

3.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.